Literature DB >> 20088924

ADAMTS-13 assays in thrombotic thrombocytopenic purpura.

F Peyvandi1, R Palla, L A Lotta, I Mackie, M A Scully, S J Machin.   

Abstract

ADAMTS-13, the thirteenth member of the ADAMTS (A Disintegrin And Metalloprotease with Thrombo-Spondin 1 repeats) family, is the plasma metalloprotease responsible for regulating the multimeric structure of VWF. In congenital or acquired deficiency it is actively involved in the pathophysiology of thrombotic thrombocytopenic purpura (TTP), a rare but life threatening disease characterized by microangiopathic haemolytic anaemia and consumptive thrombocytopenia leading to disseminated microvascular thrombosis and variable signs and symptoms of organ ischemia and damage. In the last few years, a number of in house and commercial laboratory assays for ADAMTS-13 and its autoantibodies have been developed. The features and clinical utility of ADAMTS-13 assays are summarized in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20088924     DOI: 10.1111/j.1538-7836.2010.03761.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  21 in total

1.  Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.

Authors:  Yosef Kalish; Amihai Rottenstreich; Deborah Rund; Sarit Hochberg-Klein
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

2.  ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension.

Authors:  Ashish Goel; P L Alagammai; Sukesh C Nair; Ian Mackie; Banumathi Ramakrishna; Jayaprakash Muliyil; Shyamkumar N Keshava; C E Eapen; Elwyn Elias
Journal:  Indian J Gastroenterol       Date:  2014-04-24

3.  Does corticosteroid treatment cause prolonged recovery and increased total bilirubin level in severe ADAMTS-13-deficient TTP patient?

Authors:  Zeynel Abidin Sayiner; Didar Yanardag Acik; Mehmet Yilmaz; Salih Subari; Ayse Ozlem Mete; M Sinan Dai
Journal:  Wien Klin Wochenschr       Date:  2015-01-10       Impact factor: 1.704

4.  Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.

Authors:  Ian Mackie; C E Eapen; Desley Neil; Andrew S Lawrie; Andrew Chitolie; Jean C Shaw; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2011-05-15       Impact factor: 3.199

5.  Escherichia coli-derived von Willebrand factor-A2 domain fluorescence/Förster resonance energy transfer proteins that quantify ADAMTS13 activity.

Authors:  Kannayakanahalli M Dayananda; Shobhit Gogia; Sriram Neelamegham
Journal:  Anal Biochem       Date:  2010-12-10       Impact factor: 3.365

6.  ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.

Authors:  Chong H Kim; Sierra C Simmons; Lance A Williams; Elizabeth M Staley; X Long Zheng; Huy P Pham
Journal:  Transfusion       Date:  2017-06-23       Impact factor: 3.157

7.  Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases.

Authors:  Koji Habe; Hideo Wada; Takeshi Matsumoto; Kohshi Ohishi; Makoto Ikejiri; Kimiko Matsubara; Tatsuhiko Morioka; Yuki Kamimoto; Tomoaki Ikeda; Naoyuki Katayama; Tsutomu Nobori; Hitoshi Mizutani
Journal:  Int J Hematol       Date:  2013-02-03       Impact factor: 2.490

8.  Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.

Authors:  Elie Azoulay; Philippe R Bauer; Eric Mariotte; Lene Russell; Paul Knoebl; Ignacio Martin-Loeches; Frédéric Pène; Kathryn Puxty; Pedro Povoa; Andreas Barratt-Due; Jose Garnacho-Montero; Julia Wendon; Laveena Munshi; Dominique Benoit; Michael von Bergwelt-Baildon; Marco Maggiorini; Paul Coppo; Spero Cataland; Agnès Veyradier; Andry Van de Louw
Journal:  Intensive Care Med       Date:  2019-10-07       Impact factor: 17.440

9.  Reference range for ADAMTS13 antigen, activity and anti-ADAMTS13 antibody in the healthy adult Singapore population

Authors:  Allison Ching Yee Tso; Christina Lai Lin Sum; Kiat Hoe Ong
Journal:  Singapore Med J       Date:  2020-06-26       Impact factor: 3.331

10.  Detection of Plasma Protease Activity Using Microsphere-Cytometry Assays with E. coli Derived Substrates: VWF Proteolysis by ADAMTS13.

Authors:  Shobhit Gogia; Chi Y Lo; Sriram Neelamegham
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.